FeesSafety
Pluang+

Sumitomo Mitsui Financial Group sees 27% upside with strong growth in international income and fintech earnings.

Analyst Insights
17 Sep 2026, 19:23 WIB
Seeking Alpha
View Source
Bullish
Sumitomo Mitsui Financial Group sees 27% upside with strong growth in international income and fintech earnings.

Sumitomo Mitsui Financial Group (SMFG) is rated a 'Buy' with a potential 27% capital gain based on a target price-to-book ratio of 2.00x. The company has raised its fiscal year 2029 international income forecast to ¥0.14 trillion, driven by growth in its Indian and Indonesian operations, with foreign return on tangible equity expected to increase from 8.9% to 20%. SMFG's fintech superapp Olive aims for ¥0.11 trillion in earnings by FY29, supported by partnerships with 7-Eleven and new advisory services. Management prioritizes dividend growth over share buybacks, committing to annual dividend increases to attract income-focused investors.

Sumitomo Mitsui Financial Group's ambitious targets and dividend plans provide context for the financial sector's performance. For readers following financial stocks, here is Pluang's market snapshot as of Sep 17, 2026 23:31 WIB: Among 74 priced Financials-sector US stocks, 57 rose and 16 fell today. Banco Santander SA (SAN) gained 2.85% to USD 14.81 with 100% buy orders and a typical hold time of 54 days. Nasdaq Inc (NDAQ) rose 2.83% to USD 91.27, also with 100% buy orders and a typical hold time of 124 days. Prospect Capital Corporation (PSEC) increased 2.73% to USD 2.26 but saw 91% sell orders and a typical hold time of 76 days.

More News

Brain cancer diagnostics market to nearly double by 2034, driven by tech advances and rising tumor cases.

Brain cancer diagnostics market to nearly double by 2034, driven by tech advances and rising tumor cases.

The global brain cancer diagnostics market is projected to grow from USD 4.1 billion in 2025 to USD 9.85 billion by 2034, at a CAGR of about 10.2%. Growth is fueled by increasing brain tumor incidence, adoption of advanced imaging and molecular diagn...

Bullish
43 minutes ago
Google switches satellite launch partner from SpaceX to Blue Origin for AI project.

Google switches satellite launch partner from SpaceX to Blue Origin for AI project.

Google initially launched its first Project Suncatcher AI satellite with SpaceX but has now signed a launch agreement with Blue Origin for a dedicated mission in early 2029. This shift comes amid SpaceX's threat to halt future Falcon 9 commercial lau...

Market News
Bullish
45 minutes ago
Adobe and Synopsys compete as top tech growth picks with distinct strengths and risks for 2027 investors.

Adobe and Synopsys compete as top tech growth picks with distinct strengths and risks for 2027 investors.

Adobe leads in creative software with strong revenue growth and a new AI partnership with Disney, offering stable long-term prospects despite management changes. Synopsys excels in semiconductor design tools, boosted by its Ansys acquisition and expa...

Bullish
46 minutes ago
Sandisk's stock drops two-thirds despite net income quadrupling, making it a potential buy at 6 times earnings.

Sandisk's stock drops two-thirds despite net income quadrupling, making it a potential buy at 6 times earnings.

Sandisk's net income for the trailing 12 months has surged to around $19.4 billion, more than four times its level in June, while its stock price has fallen to about a third of its June peak. This drop means the stock now trades at roughly 6 times ea...

Market News
Bullish
47 minutes ago
Vertex and Regeneron rebound with strong drug pipelines and new product approvals boosting growth.

Vertex and Regeneron rebound with strong drug pipelines and new product approvals boosting growth.

Vertex Pharmaceuticals is poised for growth with potential FDA approval of povetacicept for kidney disease and a strong cystic fibrosis drug franchise, alongside a $10 billion acquisition expanding its pipeline. Regeneron is thriving with Dupixent's ...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App